Delivery Order SPE2DB20D1100-SPE2DB25FE5H6
- Not listed
- The Defense Logistics Agency awarded a $1,935.74 delivery order to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (30-count units) under a firm fixed price contract type. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025. This contract represents a non-set-aside, competitively awarded delivery order, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of ADDYI 100 mg tablets (30-count unit dose packaging) with a contract ceiling value of $6,180.54 and an ultimate completion date of August 4, 2025. This delivery order represents a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $5,184.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADDYI (flibanserina) 100 mg tablets in quantities of 30 units. This delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award was made through open competition with no set-aside designation. AmerisourceBergen, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,935.74 to AmerisourceBergen Drug Corp for ADDYI (flibanserin) 100 mg tablets in quantities of 30 on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The product...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,102.82 to AmerisourceBergen Drug Corp for ADDYI (flibanserin) 100 mg tablets in quantities of 30 units. This firm fixed price, non-set-aside delivery order was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (flibanserin) in a quantity of 30 units, valued at $5,525.08. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location in the same city. This delivery order is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,102.17 delivery order contract is for the provision of ADDYI 100 MG TABLET medical products, with a completion date of March 7, 2025. The contract has a firm fixed price pricing type and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,382.32, is for the delivery of ADDYI 100 MG TABLET UU 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of September 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ADDYI 100 MG TABLET UU 30S. The firm fixed-price contract has a ceiling value of $3,720.22 and a completion date of November 22, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
- This federal contract award is for the delivery of ADDYI 100 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $9,214.44 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE5H6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $11.3K to AmerisourceBergen Drug Corp for 30-count tablets of ADDYI 100 mg on September 8, 2025, with completion targeted for September 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's ongoing supply of pharmaceutical products to support federal medical procurement needs. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, AmerisourceBergen maintains an extensive portfolio of federal medical supply contracts covering a comprehensive range of pharmaceuticals and medical devices. The company's capacity to fulfill varied and specialized medical supply requirements through competitive federal procurement demonstrates its significance within the Defense Logistics Agency's pharmaceutical supply chain supporting military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.3k | 9/8/25 |